Locations:

Brain Health

23-NEU-3559063_dementia_650x450
February 17, 2023/Neurosciences/Brain Health

Dementia With Initial Nonamnestic Symptoms Predicts Rapid Course

New findings have important implications for clinical trial design

22-NEU-3482371 Alzheimers-brain-650×450
January 12, 2023/Neurosciences/Brain Health

Does Peripheral Inflammation Drive Alzheimer’s Disease Progression?

New research explores the role of immune cell and blood-brain barrier changes

Brain research

Deep Learning Framework Unveiled for Identifying Risk Genes and Drug Targets in Alzheimer’s Disease

Open-source artificial intelligence technology uses human genetic data to find candidate drugs

22-NEU-3450073-CQD-Hero-650×450
December 13, 2022/Neurosciences/Brain Health

What’s the State of Anti-Amyloid Therapy in the Wake of Initial Clarity AD Findings?

Experts weigh in on the amyloid hypothesis and how to use lecanemab if approved

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Lewy body
September 30, 2022/Neurosciences/Brain Health

Dementia With Lewy Bodies Consortium Extends Research Efforts With $10.7M NIH Renewal Grant

Will enable sharper focus on new diagnostic tools for elusive neurodegenerative disease

22-NEU-3252500-CQD-Hero-650×450
September 22, 2022/Neurosciences/Brain Health

Study Suggests Brain Resiliency After Professional Fighters Retire

Neuropsychological, serum and MRI measures improve over time relative to active fighters

Brain gears concept
March 18, 2022/Behavioral Health

Initial Cognitive Manifestation of Dementia Predicts Later Behavioral Symptoms

Risk of agitation, delusions, personality change and more is shaped by early presentation

Sildenafil

Sildenafil Emerges as a Candidate Drug for Alzheimer’s Disease

69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies

Stock image of genetic testing

Clinical Diagnosis of Alzheimer’s Disease Depends on Both Clinical and Biomarker Evidence

Both are essential, say updated International Working Group recommendations

20-NEU-2021310 Sleep and circadian_CQD_650x450_Hero

The Role of Circadian Rhythm and Sleep Dysfunction in Alzheimer’s Pathophysiology

New insights into shared inflammatory pathways and immune responses

BackPage 5 of 6Next

Advertisement

Ad